TMCI
TREACE MEDICAL CONCEPTS, INC.
TREACE MEDICAL CONCEPTS, INC. (TMCI) has 5 SEC Form 4 filings (9 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jun 12, 2026.
The most active filer is Chief Executive Officer Treace John T. with 6 filings. Insiders have net bought $829K over the trailing 6 months.
- Industry:Medical - Devices
- CEO:John T. Treace
- Employees:477
- HQ:Ponte Vedra, FL, US
- IPO:2021-04-23
Insider Buying
$829K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$274.4M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Executive Officer | Purchase | 44,145 | $178K | Jun 12 | SEC ↗ | |
| Chief Executive Officer | Purchase | 32,778 | $133K | Jun 12 | SEC ↗ | |
| Chief Executive Officer | Purchase | 50,000 | $178K | Jun 1 | SEC ↗ | |
Treace John T.First filing | Chief Executive Officer | Purchase | 4,508 | $13K | May 28 | SEC ↗ |
Treace John T.First filing | Chief Executive Officer | Purchase | 49,810 | $143K | May 28 | SEC ↗ |
Treace John T.First filing | Chief Executive Officer | Purchase | 61,202 | $185K | May 28 | SEC ↗ |
Related companies
TREACE MEDICAL CONCEPTS, INC. is in the Healthcare sector.